Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of Gastroenterological Surgery|November 7, 2025
Impact of Ghrelin-Depleting Gastrectomy on Long-Term Endocrine and Metabolic Health With a Focus on Skeletal Muscle and Bone Mineral ContentHiroki Harada, Takuya Goto, Keishi Yamashita, et al.
Annals of Gastroenterological Surgery|January 5, 2026
Gastric Distension Index: A Novel Radiographic Marker Associated With Postoperative Gastric Stasis After GastrectomyHiroki Harada, Yoshiko Yamaoka, Akiko Watanabe, et al.
Surgical Oncology|June 6, 2026
Pancreas-contactless open gastrectomy for gastric cancer and postoperative pancreatic complications: A retrospective cohort studyShohei Fujita, Hiroki Harada, Kota Okuno, et al.
Surgical Oncology|May 26, 2026
Appetite-preserving gastrectomy attenuates early postoperative deterioration of bone quality after surgery in esophagogastric junction cancerHiroki Harada, Hiroyuki Minoura, Kota Okuno, et al.
Surgical Case Reports|December 29, 2025
Jejunal Enterotomy for Specimen Retrieval in D-LECS: A Case ReportKota Okuno, Hiroki Harada, Takuya Wada, et al.
Surgical Case Reports|March 17, 2025
A Case of Hypoglycemia Diagnosed by Neuropsychiatric Symptoms after Distal Gastrectomy and Total ColectomyKota Okuno, Masahiro Niihara, Shohei Fujita, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 13, 2025
Clinical utility impact of DNA-based cytology using droplet digital methylation-specific PCR in gastric cancerHiroki Harada, Takafumi Soeno, Akira Ooki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 18, 2025
Appetite-preserving gastrectomy (APG) for esophagogastric junction cancer: preserving the residual stomach as an endocrine organNaoki Hiki, Tadashi Higuchi, Koshi Kumagai, et al.
Journal of Gastroenterology|February 21, 2026
A phase I/II clinical trial of neoadjuvant docetaxel/oxaliplatin/S‑1 (DOS) combination therapy for gastroesophageal junction adenocarcinomaKoshi Kumagai, Kei Hosoda, Chikatoshi Katada, et al.
Plos One|April 1, 2024
CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancerKota Okuno, Kyonosuke Ikemura, Riku Okamoto, et al.
Pageof 2